APO Research
Talk to an analyst

APO RESEARCH · REPORT

Oral Vaccine Delivery

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Oral Vaccine Delivery Market Analysis and Forecast 2026-2032

22 December 2025198 pages

Choose your research edition.

Industry ResearchOral Vaccine Delivery Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Oral Vaccine Delivery Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Oral Vaccine Delivery Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Oral Vaccine Delivery Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Oral Vaccine Delivery Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Oral Vaccine Delivery market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Oral Vaccine Delivery is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Oral Vaccine Delivery is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Oral Vaccine Delivery is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Oral Vaccine Delivery is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Oral Vaccine Delivery include Lanzhou Institute, Sanofi, Merck, Shanghai United Cell, GSK, Valneva, Vabiotech, Tiantan Biological and Serum Institute, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Oral Vaccine Delivery, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Oral Vaccine Delivery, also provides the sales of main regions and countries. Of the upcoming market potential for Oral Vaccine Delivery, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Oral Vaccine Delivery sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Oral Vaccine Delivery market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Oral Vaccine Delivery sales, projected growth trends, production technology, application and end-user industry.

Oral Vaccine Delivery Segment by Company

Lanzhou Institute

Sanofi

Merck

Shanghai United Cell

GSK

Valneva

Vabiotech

Tiantan Biological

Serum Institute

PaxVax

Panacea Biotec Ltd

Halfkin Bio-Pharmaceuticals

EuBiologics

Bio-Med

Bibcol

Oral Vaccine Delivery Segment by Type

Rotavirus Vaccine

Oral Polio Vaccine

Cholera Vaccine

Other

Oral Vaccine Delivery Segment by Application

Public

Private

Oral Vaccine Delivery Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oral Vaccine Delivery market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oral Vaccine Delivery and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oral Vaccine Delivery.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Oral Vaccine Delivery in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Oral Vaccine Delivery manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Oral Vaccine Delivery sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Oral Vaccine Delivery Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Rotavirus Vaccine Major Manufacturers Table 3. Oral Polio Vaccine Major Manufacturers Table 4. Cholera Vaccine Major Manufacturers Table 5. Other Major Manufacturers Table 6. Global Oral Vaccine Delivery Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Public Major Manufacturers Table 8. Private Major Manufacturers Table 9. Oral Vaccine Delivery Industry Trends Table 10. Oral Vaccine Delivery Industry Drivers Table 11. Oral Vaccine Delivery Industry Opportunities and Challenges Table 12. Oral Vaccine Delivery Industry Restraints Table 13. Global Oral Vaccine Delivery Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Oral Vaccine Delivery Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Oral Vaccine Delivery Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Oral Vaccine Delivery Revenue Market Share by Region (2021-2026) Table 17. Global Oral Vaccine Delivery Revenue Market Share by Region (2027-2032) Table 18. Global Oral Vaccine Delivery Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 19. Global Oral Vaccine Delivery Sales by Region (2021-2026) & (k units) Table 20. Global Oral Vaccine Delivery Sales by Region (2027-2032) & (k units) Table 21. Global Oral Vaccine Delivery Sales Market Share by Region (2021-2026) Table 22. Global Oral Vaccine Delivery Sales Market Share by Region (2027-2032) Table 23. Global Oral Vaccine Delivery Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Oral Vaccine Delivery Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Oral Vaccine Delivery Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Oral Vaccine Delivery Sales Market Share by Manufacturers (2021-2026) Table 27. Global Oral Vaccine Delivery Sales Price (US$/unit) of Manufacturers (2021-2026) Table 28. Global Oral Vaccine Delivery Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Oral Vaccine Delivery Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Oral Vaccine Delivery Manufacturers, Product Type & Application Table 31. Global Oral Vaccine Delivery Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Oral Vaccine Delivery by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Oral Vaccine Delivery Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Oral Vaccine Delivery Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Oral Vaccine Delivery Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Oral Vaccine Delivery Revenue Market Share by Type (2021-2026) Table 38. Global Oral Vaccine Delivery Revenue Market Share by Type (2027-2032) Table 39. Global Oral Vaccine Delivery Sales by Type 2021 VS 2025 VS 2032 (k units) Table 40. Global Oral Vaccine Delivery Sales by Type (2021-2026) & (k units) Table 41. Global Oral Vaccine Delivery Sales by Type (2027-2032) & (k units) Table 42. Global Oral Vaccine Delivery Sales Market Share by Type (2021-2026) Table 43. Global Oral Vaccine Delivery Sales Market Share by Type (2027-2032) Table 44. Global Oral Vaccine Delivery Price by Type (2021-2026) & (US$/unit) Table 45. Global Oral Vaccine Delivery Price by Type (2027-2032) & (US$/unit) Table 46. Global Oral Vaccine Delivery Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Oral Vaccine Delivery Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Oral Vaccine Delivery Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Oral Vaccine Delivery Revenue Market Share by Application (2021-2026) Table 50. Global Oral Vaccine Delivery Revenue Market Share by Application (2027-2032) Table 51. Global Oral Vaccine Delivery Sales by Application 2021 VS 2025 VS 2032 (k units) Table 52. Global Oral Vaccine Delivery Sales by Application (2021-2026) & (k units) Table 53. Global Oral Vaccine Delivery Sales by Application (2027-2032) & (k units) Table 54. Global Oral Vaccine Delivery Sales Market Share by Application (2021-2026) Table 55. Global Oral Vaccine Delivery Sales Market Share by Application (2027-2032) Table 56. Global Oral Vaccine Delivery Price by Application (2021-2026) & (US$/unit) Table 57. Global Oral Vaccine Delivery Price by Application (2027-2032) & (US$/unit) Table 58. Lanzhou Institute Company Information Table 59. Lanzhou Institute Business Overview Table 60. Lanzhou Institute Oral Vaccine Delivery Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 61. Lanzhou Institute Oral Vaccine Delivery Product Portfolio Table 62. Lanzhou Institute Recent Development Table 63. Sanofi Company Information Table 64. Sanofi Business Overview Table 65. Sanofi Oral Vaccine Delivery Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 66. Sanofi Oral Vaccine Delivery Product Portfolio Table 67. Sanofi Recent Development Table 68. Merck Company Information Table 69. Merck Business Overview Table 70. Merck Oral Vaccine Delivery Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. Merck Oral Vaccine Delivery Product Portfolio Table 72. Merck Recent Development Table 73. Shanghai United Cell Company Information Table 74. Shanghai United Cell Business Overview Table 75. Shanghai United Cell Oral Vaccine Delivery Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Shanghai United Cell Oral Vaccine Delivery Product Portfolio Table 77. Shanghai United Cell Recent Development Table 78. GSK Company Information Table 79. GSK Business Overview Table 80. GSK Oral Vaccine Delivery Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. GSK Oral Vaccine Delivery Product Portfolio Table 82. GSK Recent Development Table 83. Valneva Company Information Table 84. Valneva Business Overview Table 85. Valneva Oral Vaccine Delivery Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. Valneva Oral Vaccine Delivery Product Portfolio Table 87. Valneva Recent Development Table 88. Vabiotech Company Information Table 89. Vabiotech Business Overview Table 90. Vabiotech Oral Vaccine Delivery Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. Vabiotech Oral Vaccine Delivery Product Portfolio Table 92. Vabiotech Recent Development Table 93. Tiantan Biological Company Information Table 94. Tiantan Biological Business Overview Table 95. Tiantan Biological Oral Vaccine Delivery Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 96. Tiantan Biological Oral Vaccine Delivery Product Portfolio Table 97. Tiantan Biological Recent Development Table 98. Serum Institute Company Information Table 99. Serum Institute Business Overview Table 100. Serum Institute Oral Vaccine Delivery Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 101. Serum Institute Oral Vaccine Delivery Product Portfolio Table 102. Serum Institute Recent Development Table 103. PaxVax Company Information Table 104. PaxVax Business Overview Table 105. PaxVax Oral Vaccine Delivery Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 106. PaxVax Oral Vaccine Delivery Product Portfolio Table 107. PaxVax Recent Development Table 108. Panacea Biotec Ltd Company Information Table 109. Panacea Biotec Ltd Business Overview Table 110. Panacea Biotec Ltd Oral Vaccine Delivery Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 111. Panacea Biotec Ltd Oral Vaccine Delivery Product Portfolio Table 112. Panacea Biotec Ltd Recent Development Table 113. Halfkin Bio-Pharmaceuticals Company Information Table 114. Halfkin Bio-Pharmaceuticals Business Overview Table 115. Halfkin Bio-Pharmaceuticals Oral Vaccine Delivery Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 116. Halfkin Bio-Pharmaceuticals Oral Vaccine Delivery Product Portfolio Table 117. Halfkin Bio-Pharmaceuticals Recent Development Table 118. EuBiologics Company Information Table 119. EuBiologics Business Overview Table 120. EuBiologics Oral Vaccine Delivery Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 121. EuBiologics Oral Vaccine Delivery Product Portfolio Table 122. EuBiologics Recent Development Table 123. Bio-Med Company Information Table 124. Bio-Med Business Overview Table 125. Bio-Med Oral Vaccine Delivery Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 126. Bio-Med Oral Vaccine Delivery Product Portfolio Table 127. Bio-Med Recent Development Table 128. Bibcol Company Information Table 129. Bibcol Business Overview Table 130. Bibcol Oral Vaccine Delivery Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 131. Bibcol Oral Vaccine Delivery Product Portfolio Table 132. Bibcol Recent Development Table 133. North America Oral Vaccine Delivery Revenue by Type (2021-2026) & (US$ Million) Table 134. North America Oral Vaccine Delivery Revenue by Type (2027-2032) & (US$ Million) Table 135. North America Oral Vaccine Delivery Sales by Type (2021-2026) & (k units) Table 136. North America Oral Vaccine Delivery Sales by Type (2027-2032) & (k units) Table 137. North America Oral Vaccine Delivery Sales Price by Type (2021-2026) & (US$/unit) Table 138. North America Oral Vaccine Delivery Sales Price by Type (2027-2032) & (US$/unit) Table 139. North America Oral Vaccine Delivery Revenue by Application (2021-2026) & (US$ Million) Table 140. North America Oral Vaccine Delivery Revenue by Application (2027-2032) & (US$ Million) Table 141. North America Oral Vaccine Delivery Sales by Application (2021-2026) & (k units) Table 142. North America Oral Vaccine Delivery Sales by Application (2027-2032) & (k units) Table 143. North America Oral Vaccine Delivery Sales Price by Application (2021-2026) & (US$/unit) Table 144. North America Oral Vaccine Delivery Sales Price by Application (2027-2032) & (US$/unit) Table 145. North America Oral Vaccine Delivery Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 146. North America Oral Vaccine Delivery Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 147. North America Oral Vaccine Delivery Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 148. North America Oral Vaccine Delivery Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 149. North America Oral Vaccine Delivery Sales by Country (2021-2026) & (k units) Table 150. North America Oral Vaccine Delivery Sales by Country (2027-2032) & (k units) Table 151. North America Oral Vaccine Delivery Sales Price by Country (2021-2026) & (US$/unit) Table 152. North America Oral Vaccine Delivery Sales Price by Country (2027-2032) & (US$/unit) Table 153. United States Oral Vaccine Delivery Revenue (2021-2032) & (US$ Million) Table 154. Canada Oral Vaccine Delivery Revenue (2021-2032) & (US$ Million) Table 155. Mexico Oral Vaccine Delivery Revenue (2021-2032) & (US$ Million) Table 156. Europe Oral Vaccine Delivery Revenue by Type (2021-2026) & (US$ Million) Table 157. Europe Oral Vaccine Delivery Revenue by Type (2027-2032) & (US$ Million) Table 158. Europe Oral Vaccine Delivery Sales by Type (2021-2026) & (k units) Table 159. Europe Oral Vaccine Delivery Sales by Type (2027-2032) & (k units) Table 160. Europe Oral Vaccine Delivery Sales Price by Type (2021-2026) & (US$/unit) Table 161. Europe Oral Vaccine Delivery Sales Price by Type (2027-2032) & (US$/unit) Table 162. Europe Oral Vaccine Delivery Revenue by Application (2021-2026) & (US$ Million) Table 163. Europe Oral Vaccine Delivery Revenue by Application (2027-2032) & (US$ Million) Table 164. Europe Oral Vaccine Delivery Sales by Application (2021-2026) & (k units) Table 165. Europe Oral Vaccine Delivery Sales by Application (2027-2032) & (k units) Table 166. Europe Oral Vaccine Delivery Sales Price by Application (2021-2026) & (US$/unit) Table 167. Europe Oral Vaccine Delivery Sales Price by Application (2027-2032) & (US$/unit) Table 168. Europe Oral Vaccine Delivery Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 169. Europe Oral Vaccine Delivery Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 170. Europe Oral Vaccine Delivery Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 171. Europe Oral Vaccine Delivery Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 172. Europe Oral Vaccine Delivery Sales by Country (2021-2026) & (k units) Table 173. Europe Oral Vaccine Delivery Sales by Country (2027-2032) & (k units) Table 174. Europe Oral Vaccine Delivery Sales Price by Country (2021-2026) & (US$/unit) Table 175. Europe Oral Vaccine Delivery Sales Price by Country (2027-2032) & (US$/unit) Table 176. Germany Oral Vaccine Delivery Revenue (2021-2032) & (US$ Million) Table 177. France Oral Vaccine Delivery Revenue (2021-2032) & (US$ Million) Table 178. U.K. Oral Vaccine Delivery Revenue (2021-2032) & (US$ Million) Table 179. Italy Oral Vaccine Delivery Revenue (2021-2032) & (US$ Million) Table 180. Russia Oral Vaccine Delivery Revenue (2021-2032) & (US$ Million) Table 181. Spain Oral Vaccine Delivery Revenue (2021-2032) & (US$ Million) Table 182. Netherlands Oral Vaccine Delivery Revenue (2021-2032) & (US$ Million) Table 183. Switzerland Oral Vaccine Delivery Revenue (2021-2032) & (US$ Million) Table 184. Sweden Oral Vaccine Delivery Revenue (2021-2032) & (US$ Million) Table 185. Poland Oral Vaccine Delivery Revenue (2021-2032) & (US$ Million) Table 186. China Oral Vaccine Delivery Revenue by Type (2021-2026) & (US$ Million) Table 187. China Oral Vaccine Delivery Revenue by Type (2027-2032) & (US$ Million) Table 188. China Oral Vaccine Delivery Sales by Type (2021-2026) & (k units) Table 189. China Oral Vaccine Delivery Sales by Type (2027-2032) & (k units) Table 190. China Oral Vaccine Delivery Sales Price by Type (2021-2026) & (US$/unit) Table 191. China Oral Vaccine Delivery Sales Price by Type (2027-2032) & (US$/unit) Table 192. China Oral Vaccine Delivery Revenue by Application (2021-2026) & (US$ Million) Table 193. China Oral Vaccine Delivery Revenue by Application (2027-2032) & (US$ Million) Table 194. China Oral Vaccine Delivery Sales by Application (2021-2026) & (k units) Table 195. China Oral Vaccine Delivery Sales by Application (2027-2032) & (k units) Table 196. China Oral Vaccine Delivery Sales Price by Application (2021-2026) & (US$/unit) Table 197. China Oral Vaccine Delivery Sales Price by Application (2027-2032) & (US$/unit) Table 198. Asia Oral Vaccine Delivery Revenue by Type (2021-2026) & (US$ Million) Table 199. Asia Oral Vaccine Delivery Revenue by Type (2027-2032) & (US$ Million) Table 200. Asia Oral Vaccine Delivery Sales by Type (2021-2026) & (k units) Table 201. Asia Oral Vaccine Delivery Sales by Type (2027-2032) & (k units) Table 202. Asia Oral Vaccine Delivery Sales Price by Type (2021-2026) & (US$/unit) Table 203. Asia Oral Vaccine Delivery Sales Price by Type (2027-2032) & (US$/unit) Table 204. Asia Oral Vaccine Delivery Revenue by Application (2021-2026) & (US$ Million) Table 205. Asia Oral Vaccine Delivery Revenue by Application (2027-2032) & (US$ Million) Table 206. Asia Oral Vaccine Delivery Sales by Application (2021-2026) & (k units) Table 207. Asia Oral Vaccine Delivery Sales by Application (2027-2032) & (k units) Table 208. Asia Oral Vaccine Delivery Sales Price by Application (2021-2026) & (US$/unit) Table 209. Asia Oral Vaccine Delivery Sales Price by Application (2027-2032) & (US$/unit) Table 210. Asia Oral Vaccine Delivery Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 211. Asia Oral Vaccine Delivery Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 212. Asia Oral Vaccine Delivery Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 213. Asia Oral Vaccine Delivery Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 214. Asia Oral Vaccine Delivery Sales by Country (2021-2026) & (k units) Table 215. Asia Oral Vaccine Delivery Sales by Country (2027-2032) & (k units) Table 216. Asia Oral Vaccine Delivery Sales Price by Country (2021-2026) & (US$/unit) Table 217. Asia Oral Vaccine Delivery Sales Price by Country (2027-2032) & (US$/unit) Table 218. Japan Oral Vaccine Delivery Revenue (2021-2032) & (US$ Million) Table 219. South Korea Oral Vaccine Delivery Revenue (2021-2032) & (US$ Million) Table 220. India Oral Vaccine Delivery Revenue (2021-2032) & (US$ Million) Table 221. Australia Oral Vaccine Delivery Revenue (2021-2032) & (US$ Million) Table 222. Taiwan Oral Vaccine Delivery Revenue (2021-2032) & (US$ Million) Table 223. Southeast Asia Oral Vaccine Delivery Revenue (2021-2032) & (US$ Million) Table 224. SAMEA Oral Vaccine Delivery Revenue by Type (2021-2026) & (US$ Million) Table 225. SAMEA Oral Vaccine Delivery Revenue by Type (2027-2032) & (US$ Million) Table 226. SAMEA Oral Vaccine Delivery Sales by Type (2021-2026) & (k units) Table 227. SAMEA Oral Vaccine Delivery Sales by Type (2027-2032) & (k units) Table 228. SAMEA Oral Vaccine Delivery Sales Price by Type (2021-2026) & (US$/unit) Table 229. SAMEA Oral Vaccine Delivery Sales Price by Type (2027-2032) & (US$/unit) Table 230. SAMEA Oral Vaccine Delivery Revenue by Application (2021-2026) & (US$ Million) Table 231. SAMEA Oral Vaccine Delivery Revenue by Application (2027-2032) & (US$ Million) Table 232. SAMEA Oral Vaccine Delivery Sales by Application (2021-2026) & (k units) Table 233. SAMEA Oral Vaccine Delivery Sales by Application (2027-2032) & (k units) Table 234. SAMEA Oral Vaccine Delivery Sales Price by Application (2021-2026) & (US$/unit) Table 235. SAMEA Oral Vaccine Delivery Sales Price by Application (2027-2032) & (US$/unit) Table 236. SAMEA Oral Vaccine Delivery Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 237. SAMEA Oral Vaccine Delivery Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 238. SAMEA Oral Vaccine Delivery Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 239. SAMEA Oral Vaccine Delivery Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 240. SAMEA Oral Vaccine Delivery Sales by Country (2021-2026) & (k units) Table 241. SAMEA Oral Vaccine Delivery Sales by Country (2027-2032) & (k units) Table 242. SAMEA Oral Vaccine Delivery Sales Price by Country (2021-2026) & (US$/unit) Table 243. SAMEA Oral Vaccine Delivery Sales Price by Country (2027-2032) & (US$/unit) Table 244. Brazil Oral Vaccine Delivery Revenue (2021-2032) & (US$ Million) Table 245. Argentina Oral Vaccine Delivery Revenue (2021-2032) & (US$ Million) Table 246. Chile Oral Vaccine Delivery Revenue (2021-2032) & (US$ Million) Table 247. Colombia Oral Vaccine Delivery Revenue (2021-2032) & (US$ Million) Table 248. Peru Oral Vaccine Delivery Revenue (2021-2032) & (US$ Million) Table 249. Saudi Arabia Oral Vaccine Delivery Revenue (2021-2032) & (US$ Million) Table 250. Israel Oral Vaccine Delivery Revenue (2021-2032) & (US$ Million) Table 251. UAE Oral Vaccine Delivery Revenue (2021-2032) & (US$ Million) Table 252. Turkey Oral Vaccine Delivery Revenue (2021-2032) & (US$ Million) Table 253. Iran Oral Vaccine Delivery Revenue (2021-2032) & (US$ Million) Table 254. Egypt Oral Vaccine Delivery Revenue (2021-2032) & (US$ Million) Table 255. Key Raw Materials Table 256. Raw Materials Key Suppliers Table 257. Oral Vaccine Delivery Distributors List Table 258. Oral Vaccine Delivery Customers List Table 259. Research Programs/Design for This Report Table 260. Authors List of This Report Table 261. Secondary Sources Table 262. Primary Sources List of Figures Figure 1. Oral Vaccine Delivery Image Figure 2. Global Oral Vaccine Delivery Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Oral Vaccine Delivery Market Size Share 2021 VS 2025 VS 2032 Figure 4. Rotavirus Vaccine Image Figure 5. Oral Polio Vaccine Image Figure 6. Cholera Vaccine Image Figure 7. Other Image Figure 8. Global Oral Vaccine Delivery Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Oral Vaccine Delivery Market Size Share 2021 VS 2025 VS 2032 Figure 10. Public Image Figure 11. Private Image Figure 12. Global Oral Vaccine Delivery Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Oral Vaccine Delivery Revenue (2021-2032) & (US$ Million) Figure 14. Global Oral Vaccine Delivery Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Oral Vaccine Delivery Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Oral Vaccine Delivery Revenue Market Share by Region (2021-2032) Figure 17. Global Oral Vaccine Delivery Sales (2021-2032) & (k units) Figure 18. Global Oral Vaccine Delivery Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 19. Global Oral Vaccine Delivery Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Oral Vaccine Delivery Sales YoY (2021-2032) & (k units) Figure 21. Europe Oral Vaccine Delivery Sales YoY (2021-2032) & (k units) Figure 22. China Oral Vaccine Delivery Sales YoY (2021-2032) & (k units) Figure 23. Asia (Excluding China) Oral Vaccine Delivery Sales YoY (2021-2032) & (k units) Figure 24. South America, Middle East and Africa Oral Vaccine Delivery Sales YoY (2021-2032) & (k units) Figure 25. Global Oral Vaccine Delivery Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Oral Vaccine Delivery Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Oral Vaccine Delivery Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Oral Vaccine Delivery Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Oral Vaccine Delivery Revenue Market Share by Type (2021-2032) Figure 31. Global Oral Vaccine Delivery Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 32. Global Oral Vaccine Delivery Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Oral Vaccine Delivery Sales Market Share by Type (2021-2032) Figure 34. Global Oral Vaccine Delivery Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Oral Vaccine Delivery Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Oral Vaccine Delivery Revenue Market Share by Application (2021-2032) Figure 37. Global Oral Vaccine Delivery Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 38. Global Oral Vaccine Delivery Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Oral Vaccine Delivery Sales Market Share by Application (2021-2032) Figure 40. North America Oral Vaccine Delivery Revenue Share by Type (2021-2032) Figure 41. North America Oral Vaccine Delivery Sales Share by Type (2021-2032) Figure 42. North America Oral Vaccine Delivery Revenue Share by Application (2021-2032) Figure 43. North America Oral Vaccine Delivery Sales Share by Application (2021-2032) Figure 44. North America Oral Vaccine Delivery Revenue Share by Country (2021-2032) Figure 45. North America Oral Vaccine Delivery Sales Share by Country (2021-2032) Figure 46. Europe Oral Vaccine Delivery Revenue Share by Type (2021-2032) Figure 47. Europe Oral Vaccine Delivery Sales Share by Type (2021-2032) Figure 48. Europe Oral Vaccine Delivery Revenue Share by Application (2021-2032) Figure 49. Europe Oral Vaccine Delivery Sales Share by Application (2021-2032) Figure 50. Europe Oral Vaccine Delivery Revenue Share by Country (2021-2032) Figure 51. Europe Oral Vaccine Delivery Sales Share by Country (2021-2032) Figure 52. China Oral Vaccine Delivery Revenue Share by Type (2021-2032) Figure 53. China Oral Vaccine Delivery Sales Share by Type (2021-2032) Figure 54. China Oral Vaccine Delivery Revenue Share by Application (2021-2032) Figure 55. China Oral Vaccine Delivery Sales Share by Application (2021-2032) Figure 56. Asia Oral Vaccine Delivery Revenue Share by Type (2021-2032) Figure 57. Asia Oral Vaccine Delivery Sales Share by Type (2021-2032) Figure 58. Asia Oral Vaccine Delivery Revenue Share by Application (2021-2032) Figure 59. Asia Oral Vaccine Delivery Sales Share by Application (2021-2032) Figure 60. Asia Oral Vaccine Delivery Revenue Share by Country (2021-2032) Figure 61. Asia Oral Vaccine Delivery Sales Share by Country (2021-2032) Figure 62. SAMEA Oral Vaccine Delivery Revenue Share by Type (2021-2032) Figure 63. SAMEA Oral Vaccine Delivery Sales Share by Type (2021-2032) Figure 64. SAMEA Oral Vaccine Delivery Revenue Share by Application (2021-2032) Figure 65. SAMEA Oral Vaccine Delivery Sales Share by Application (2021-2032) Figure 66. SAMEA Oral Vaccine Delivery Revenue Share by Country (2021-2032) Figure 67. SAMEA Oral Vaccine Delivery Sales Share by Country (2021-2032) Figure 68. Oral Vaccine Delivery Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Oral Vaccine Delivery Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Rotavirus Vaccine
  • Oral Polio Vaccine
  • Cholera Vaccine
  • Other
Applications
  • Public
  • Private
Companies covered
  • Lanzhou Institute
  • Sanofi
  • Merck
  • Shanghai United Cell
  • GSK
  • Valneva
  • Vabiotech
  • Tiantan Biological
  • Serum Institute
  • PaxVax
  • Panacea Biotec Ltd
  • Halfkin Bio-Pharmaceuticals
  • EuBiologics
  • Bio-Med
  • Bibcol

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Oral Vaccine Delivery Market by Type
  3. 1.2.1 Global Oral Vaccine Delivery Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Rotavirus Vaccine
  5. 1.2.3 Oral Polio Vaccine
  6. 1.2.4 Cholera Vaccine
  7. 1.2.5 Other
  8. 1.3 Oral Vaccine Delivery Market by Application
  9. 1.3.1 Global Oral Vaccine Delivery Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Public
  11. 1.3.3 Private
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Oral Vaccine Delivery Market Dynamics
  1. 2.1 Oral Vaccine Delivery Industry Trends
  2. 2.2 Oral Vaccine Delivery Industry Drivers
  3. 2.3 Oral Vaccine Delivery Industry Opportunities and Challenges
  4. 2.4 Oral Vaccine Delivery Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Oral Vaccine Delivery Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Oral Vaccine Delivery Revenue by Region
  3. 3.2.1 Global Oral Vaccine Delivery Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Oral Vaccine Delivery Revenue by Region (2021-2026)
  5. 3.2.3 Global Oral Vaccine Delivery Revenue by Region (2027-2032)
  6. 3.2.4 Global Oral Vaccine Delivery Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Oral Vaccine Delivery Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Oral Vaccine Delivery Sales by Region
  9. 3.4.1 Global Oral Vaccine Delivery Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Oral Vaccine Delivery Sales by Region (2021-2026)
  11. 3.4.3 Global Oral Vaccine Delivery Sales by Region (2027-2032)
  12. 3.4.4 Global Oral Vaccine Delivery Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Oral Vaccine Delivery Revenue by Manufacturers
  2. 4.1.1 Global Oral Vaccine Delivery Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Oral Vaccine Delivery Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Oral Vaccine Delivery Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Oral Vaccine Delivery Sales by Manufacturers
  6. 4.2.1 Global Oral Vaccine Delivery Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Oral Vaccine Delivery Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Oral Vaccine Delivery Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Oral Vaccine Delivery Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Oral Vaccine Delivery Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Oral Vaccine Delivery Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Oral Vaccine Delivery Manufacturers, Product Type & Application
  13. 4.7 Global Oral Vaccine Delivery Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Oral Vaccine Delivery Market CR5 and HHI
  16. 4.8.2 2025 Oral Vaccine Delivery Tier 1, Tier 2, and Tier 3
5 Oral Vaccine Delivery Market by Type
  1. 5.1 Global Oral Vaccine Delivery Revenue by Type
  2. 5.1.1 Global Oral Vaccine Delivery Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Oral Vaccine Delivery Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Oral Vaccine Delivery Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Oral Vaccine Delivery Sales by Type
  6. 5.2.1 Global Oral Vaccine Delivery Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Oral Vaccine Delivery Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Oral Vaccine Delivery Sales Market Share by Type (2021-2032)
  9. 5.3 Global Oral Vaccine Delivery Price by Type
6 Oral Vaccine Delivery Market by Application
  1. 6.1 Global Oral Vaccine Delivery Revenue by Application
  2. 6.1.1 Global Oral Vaccine Delivery Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Oral Vaccine Delivery Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Oral Vaccine Delivery Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Oral Vaccine Delivery Sales by Application
  6. 6.2.1 Global Oral Vaccine Delivery Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Oral Vaccine Delivery Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Oral Vaccine Delivery Sales Market Share by Application (2021-2032)
  9. 6.3 Global Oral Vaccine Delivery Price by Application
7 Company Profiles
  1. 7.1 Lanzhou Institute
  2. 7.1.1 Lanzhou Institute Company Information
  3. 7.1.2 Lanzhou Institute Business Overview
  4. 7.1.3 Lanzhou Institute Oral Vaccine Delivery Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Lanzhou Institute Oral Vaccine Delivery Product Portfolio
  6. 7.1.5 Lanzhou Institute Recent Developments
  7. 7.2 Sanofi
  8. 7.2.1 Sanofi Company Information
  9. 7.2.2 Sanofi Business Overview
  10. 7.2.3 Sanofi Oral Vaccine Delivery Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Sanofi Oral Vaccine Delivery Product Portfolio
  12. 7.2.5 Sanofi Recent Developments
  13. 7.3 Merck
  14. 7.3.1 Merck Company Information
  15. 7.3.2 Merck Business Overview
  16. 7.3.3 Merck Oral Vaccine Delivery Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Merck Oral Vaccine Delivery Product Portfolio
  18. 7.3.5 Merck Recent Developments
  19. 7.4 Shanghai United Cell
  20. 7.4.1 Shanghai United Cell Company Information
  21. 7.4.2 Shanghai United Cell Business Overview
  22. 7.4.3 Shanghai United Cell Oral Vaccine Delivery Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Shanghai United Cell Oral Vaccine Delivery Product Portfolio
  24. 7.4.5 Shanghai United Cell Recent Developments
  25. 7.5 GSK
  26. 7.5.1 GSK Company Information
  27. 7.5.2 GSK Business Overview
  28. 7.5.3 GSK Oral Vaccine Delivery Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 GSK Oral Vaccine Delivery Product Portfolio
  30. 7.5.5 GSK Recent Developments
  31. 7.6 Valneva
  32. 7.6.1 Valneva Company Information
  33. 7.6.2 Valneva Business Overview
  34. 7.6.3 Valneva Oral Vaccine Delivery Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Valneva Oral Vaccine Delivery Product Portfolio
  36. 7.6.5 Valneva Recent Developments
  37. 7.7 Vabiotech
  38. 7.7.1 Vabiotech Company Information
  39. 7.7.2 Vabiotech Business Overview
  40. 7.7.3 Vabiotech Oral Vaccine Delivery Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Vabiotech Oral Vaccine Delivery Product Portfolio
  42. 7.7.5 Vabiotech Recent Developments
  43. 7.8 Tiantan Biological
  44. 7.8.1 Tiantan Biological Company Information
  45. 7.8.2 Tiantan Biological Business Overview
  46. 7.8.3 Tiantan Biological Oral Vaccine Delivery Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Tiantan Biological Oral Vaccine Delivery Product Portfolio
  48. 7.8.5 Tiantan Biological Recent Developments
  49. 7.9 Serum Institute
  50. 7.9.1 Serum Institute Company Information
  51. 7.9.2 Serum Institute Business Overview
  52. 7.9.3 Serum Institute Oral Vaccine Delivery Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Serum Institute Oral Vaccine Delivery Product Portfolio
  54. 7.9.5 Serum Institute Recent Developments
  55. 7.10 PaxVax
  56. 7.10.1 PaxVax Company Information
  57. 7.10.2 PaxVax Business Overview
  58. 7.10.3 PaxVax Oral Vaccine Delivery Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 PaxVax Oral Vaccine Delivery Product Portfolio
  60. 7.10.5 PaxVax Recent Developments
  61. 7.11 Panacea Biotec Ltd
  62. 7.11.1 Panacea Biotec Ltd Company Information
  63. 7.11.2 Panacea Biotec Ltd Business Overview
  64. 7.11.3 Panacea Biotec Ltd Oral Vaccine Delivery Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Panacea Biotec Ltd Oral Vaccine Delivery Product Portfolio
  66. 7.11.5 Panacea Biotec Ltd Recent Developments
  67. 7.12 Halfkin Bio-Pharmaceuticals
  68. 7.12.1 Halfkin Bio-Pharmaceuticals Company Information
  69. 7.12.2 Halfkin Bio-Pharmaceuticals Business Overview
  70. 7.12.3 Halfkin Bio-Pharmaceuticals Oral Vaccine Delivery Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Halfkin Bio-Pharmaceuticals Oral Vaccine Delivery Product Portfolio
  72. 7.12.5 Halfkin Bio-Pharmaceuticals Recent Developments
  73. 7.13 EuBiologics
  74. 7.13.1 EuBiologics Company Information
  75. 7.13.2 EuBiologics Business Overview
  76. 7.13.3 EuBiologics Oral Vaccine Delivery Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 EuBiologics Oral Vaccine Delivery Product Portfolio
  78. 7.13.5 EuBiologics Recent Developments
  79. 7.14 Bio-Med
  80. 7.14.1 Bio-Med Company Information
  81. 7.14.2 Bio-Med Business Overview
  82. 7.14.3 Bio-Med Oral Vaccine Delivery Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Bio-Med Oral Vaccine Delivery Product Portfolio
  84. 7.14.5 Bio-Med Recent Developments
  85. 7.15 Bibcol
  86. 7.15.1 Bibcol Company Information
  87. 7.15.2 Bibcol Business Overview
  88. 7.15.3 Bibcol Oral Vaccine Delivery Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Bibcol Oral Vaccine Delivery Product Portfolio
  90. 7.15.5 Bibcol Recent Developments
8 North America
  1. 8.1 North America Oral Vaccine Delivery Market Size by Type
  2. 8.1.1 North America Oral Vaccine Delivery Revenue by Type (2021-2032)
  3. 8.1.2 North America Oral Vaccine Delivery Sales by Type (2021-2032)
  4. 8.1.3 North America Oral Vaccine Delivery Price by Type (2021-2032)
  5. 8.2 North America Oral Vaccine Delivery Market Size by Application
  6. 8.2.1 North America Oral Vaccine Delivery Revenue by Application (2021-2032)
  7. 8.2.2 North America Oral Vaccine Delivery Sales by Application (2021-2032)
  8. 8.2.3 North America Oral Vaccine Delivery Price by Application (2021-2032)
  9. 8.3 North America Oral Vaccine Delivery Market Size by Country
  10. 8.3.1 North America Oral Vaccine Delivery Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Oral Vaccine Delivery Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Oral Vaccine Delivery Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Oral Vaccine Delivery Market Size by Type
  2. 9.1.1 Europe Oral Vaccine Delivery Revenue by Type (2021-2032)
  3. 9.1.2 Europe Oral Vaccine Delivery Sales by Type (2021-2032)
  4. 9.1.3 Europe Oral Vaccine Delivery Price by Type (2021-2032)
  5. 9.2 Europe Oral Vaccine Delivery Market Size by Application
  6. 9.2.1 Europe Oral Vaccine Delivery Revenue by Application (2021-2032)
  7. 9.2.2 Europe Oral Vaccine Delivery Sales by Application (2021-2032)
  8. 9.2.3 Europe Oral Vaccine Delivery Price by Application (2021-2032)
  9. 9.3 Europe Oral Vaccine Delivery Market Size by Country
  10. 9.3.1 Europe Oral Vaccine Delivery Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Oral Vaccine Delivery Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Oral Vaccine Delivery Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Oral Vaccine Delivery Market Size by Type
  2. 10.1.1 China Oral Vaccine Delivery Revenue by Type (2021-2032)
  3. 10.1.2 China Oral Vaccine Delivery Sales by Type (2021-2032)
  4. 10.1.3 China Oral Vaccine Delivery Price by Type (2021-2032)
  5. 10.2 China Oral Vaccine Delivery Market Size by Application
  6. 10.2.1 China Oral Vaccine Delivery Revenue by Application (2021-2032)
  7. 10.2.2 China Oral Vaccine Delivery Sales by Application (2021-2032)
  8. 10.2.3 China Oral Vaccine Delivery Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Oral Vaccine Delivery Market Size by Type
  2. 11.1.1 Asia Oral Vaccine Delivery Revenue by Type (2021-2032)
  3. 11.1.2 Asia Oral Vaccine Delivery Sales by Type (2021-2032)
  4. 11.1.3 Asia Oral Vaccine Delivery Price by Type (2021-2032)
  5. 11.2 Asia Oral Vaccine Delivery Market Size by Application
  6. 11.2.1 Asia Oral Vaccine Delivery Revenue by Application (2021-2032)
  7. 11.2.2 Asia Oral Vaccine Delivery Sales by Application (2021-2032)
  8. 11.2.3 Asia Oral Vaccine Delivery Price by Application (2021-2032)
  9. 11.3 Asia Oral Vaccine Delivery Market Size by Country
  10. 11.3.1 Asia Oral Vaccine Delivery Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Oral Vaccine Delivery Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Oral Vaccine Delivery Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Oral Vaccine Delivery Market Size by Type
  2. 12.1.1 SAMEA Oral Vaccine Delivery Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Oral Vaccine Delivery Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Oral Vaccine Delivery Price by Type (2021-2032)
  5. 12.2 SAMEA Oral Vaccine Delivery Market Size by Application
  6. 12.2.1 SAMEA Oral Vaccine Delivery Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Oral Vaccine Delivery Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Oral Vaccine Delivery Price by Application (2021-2032)
  9. 12.3 SAMEA Oral Vaccine Delivery Market Size by Country
  10. 12.3.1 SAMEA Oral Vaccine Delivery Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Oral Vaccine Delivery Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Oral Vaccine Delivery Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Oral Vaccine Delivery Value Chain Analysis
  2. 13.1.1 Oral Vaccine Delivery Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Oral Vaccine Delivery Production Mode & Process
  6. 13.2 Oral Vaccine Delivery Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Oral Vaccine Delivery Distributors
  9. 13.2.3 Oral Vaccine Delivery Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst